Park et al. Risk-benefit of PJP propylaxis in rituximab treated patients. NNH 86 . NNT - all RTX 146, RTX+high dose steroid 21. This mirrors my practice @RheumNow #ACR22 Abstr#0720 https://t.co/JPtPCqah9R https://t.co/bonRzWFbVw
Links:
Risk-Benefit Assessment of Primary Prophylaxis for Pneumocystis Pneumonia in Pa…
https://acrabstracts.org/abstract/risk-benefit-assessment-of-primary-prophylaxi…
13-11-2022
